This study provided evidence that GH-RH plays important roles in prostatic inflammation and EMT, suggesting the merit of clinical investigation to elucidate the effects of GH-RH antagonists in prostatitis and BPH. The gene discussed is GHRH; the disease is urogenital neoplasm.